• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSK的调控、靶点及功能。

Regulation, targets and functions of CSK.

作者信息

Zhu Shudong, Wang Hui, Ranjan Kamakshi, Zhang Dianzheng

机构信息

School of Medicine, Nantong University, Nantong, China.

Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United States.

出版信息

Front Cell Dev Biol. 2023 Jun 16;11:1206539. doi: 10.3389/fcell.2023.1206539. eCollection 2023.

DOI:10.3389/fcell.2023.1206539
PMID:37397251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10312003/
Abstract

The Src family kinases (SFK) plays an important role in multiple signal transduction pathways. Aberrant activation of SFKs leads to diseases such as cancer, blood disorders, and bone pathologies. By phosphorylating and inactivating SFKs, the C-terminal Src kinase (CSK) serves as the key negative regulator of SFKs. Similar to Src, CSK is composed of SH3, SH2, and a catalytic kinase domain. However, while the Src kinase domain is intrinsically active, the CSK kinase domain is intrinsically inactive. Multiple lines of evidence indicate that CSK is involved in various physiological processes including DNA repair, permeability of intestinal epithelial cells (IECs), synaptic activity, astrocyte-to-neuron communication, erythropoiesis, platelet homeostasis, mast cell activation, immune and inflammation responses. As a result, dysregulation of CSK may lead to many diseases with different underlying molecular mechanisms. Furthermore, recent findings suggest that in addition to the well-established CSK-SFK axis, novel CSK-related targets and modes of CSK regulation also exist. This review focuses on the recent progress in this field for an up-to-date understanding of CSK.

摘要

Src家族激酶(SFK)在多种信号转导途径中发挥重要作用。SFK的异常激活会导致癌症、血液疾病和骨骼疾病等病症。通过磷酸化并使SFK失活,C末端Src激酶(CSK)充当SFK的关键负调节因子。与Src相似,CSK由SH3、SH2和一个催化激酶结构域组成。然而,虽然Src激酶结构域具有内在活性,但CSK激酶结构域是内在无活性的。多项证据表明,CSK参与多种生理过程,包括DNA修复、肠上皮细胞(IEC)通透性、突触活动、星形胶质细胞与神经元的通信、红细胞生成、血小板稳态、肥大细胞激活、免疫和炎症反应。因此,CSK的失调可能导致许多具有不同潜在分子机制的疾病。此外,最近的研究结果表明,除了已确立的CSK-SFK轴外,还存在与CSK相关的新靶点和CSK调节模式。本综述重点关注该领域的最新进展,以便对CSK有最新的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1966/10312003/a3c24ab06585/fcell-11-1206539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1966/10312003/267ef99030f4/fcell-11-1206539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1966/10312003/a3c24ab06585/fcell-11-1206539-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1966/10312003/267ef99030f4/fcell-11-1206539-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1966/10312003/a3c24ab06585/fcell-11-1206539-g002.jpg

相似文献

1
Regulation, targets and functions of CSK.CSK的调控、靶点及功能。
Front Cell Dev Biol. 2023 Jun 16;11:1206539. doi: 10.3389/fcell.2023.1206539. eCollection 2023.
2
Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.Csk 同源激酶(Chk)是Src 家族激酶的有效抑制剂,但对其 C 末端调节性酪氨酸的磷酸化催化作用较差。
Cell Commun Signal. 2017 Aug 7;15(1):29. doi: 10.1186/s12964-017-0186-x.
3
C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.C端Src激酶同源激酶(CHK),一种使Src家族酪氨酸激酶的多种活性构象失活的独特抑制剂。
J Biol Chem. 2006 Nov 3;281(44):32988-99. doi: 10.1074/jbc.M602951200. Epub 2006 Sep 7.
4
C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.C端Src激酶(CSK)和CSK同源激酶(CHK)——Src家族蛋白激酶的内源性负调控因子。
Growth Factors. 2005 Sep;23(3):233-44. doi: 10.1080/08977190500178877.
5
Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.酪氨酸激酶 Chk 和 Csk 与磷酸酶 PTPRJ 之间的相互作用对于调节小鼠血小板至关重要。
Blood. 2020 Apr 30;135(18):1574-1587. doi: 10.1182/blood.2019002848.
6
Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.调控和催化CSK家族激酶及其对Src家族激酶抑制作用的结构元件和变构机制。
Growth Factors. 2010 Oct;28(5):329-50. doi: 10.3109/08977194.2010.484424.
7
Structure of the carboxyl-terminal Src kinase, Csk.羧基末端Src激酶Csk的结构
J Biol Chem. 2002 Apr 26;277(17):14351-4. doi: 10.1074/jbc.C200086200. Epub 2002 Mar 7.
8
Apoptosis regulation by the tyrosine-protein kinase CSK.酪氨酸蛋白激酶CSK对细胞凋亡的调控
Front Cell Dev Biol. 2022 Dec 12;10:1078180. doi: 10.3389/fcell.2022.1078180. eCollection 2022.
9
A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity.C端Src同源激酶用于抑制Src家族激酶活性的一种新型非催化机制。
J Biol Chem. 2004 May 14;279(20):20752-66. doi: 10.1074/jbc.M309865200. Epub 2004 Feb 25.
10
Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.Src家族蛋白酪氨酸激酶的内源性和合成抑制剂。
Biochim Biophys Acta. 2005 Dec 30;1754(1-2):210-20. doi: 10.1016/j.bbapap.2005.07.027. Epub 2005 Sep 8.

引用本文的文献

1
Scaffold-Hopping Design and Synthesis of Thieno[3,2-]pyrimidines: Anticancer Activity, Apoptosis Induction, and In Silico Inhibition of CDKs.噻吩并[3,2 -]嘧啶的骨架跃迁设计与合成:抗癌活性、凋亡诱导及对细胞周期蛋白依赖性激酶的计算机模拟抑制
Int J Mol Sci. 2025 Sep 2;26(17):8528. doi: 10.3390/ijms26178528.
2
IGF2BP3 Triggers STAT3 Pathway by Stabilizing SRC RNA in an m6A-Dependent Manner to Promote Lymphatic Metastasis in LUAD.IGF2BP3通过以m6A依赖的方式稳定SRC RNA触发STAT3信号通路,促进肺腺癌的淋巴转移。
Cancer Sci. 2025 Apr;116(4):936-950. doi: 10.1111/cas.16451. Epub 2025 Jan 13.
3
Csk controls leukocyte extravasation via local regulation of Src family kinases and cortactin signaling.

本文引用的文献

1
Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase.Csk蛋白酪氨酸激酶的催化和调节结构-功能关系剖析
Front Cell Dev Biol. 2023 Mar 1;11:1148352. doi: 10.3389/fcell.2023.1148352. eCollection 2023.
2
Integration of fingerprint-based similarity searching and kernel-based partial least squares analysis to predict inhibitory activity against CSK, HER2, JAK1, JAK2, and JAK3.基于指纹的相似性搜索与基于核的偏最小二乘法分析相结合,预测对 CSK、HER2、JAK1、JAK2 和 JAK3 的抑制活性。
Mol Divers. 2024 Apr;28(2):497-507. doi: 10.1007/s11030-022-10596-1. Epub 2023 Jan 17.
3
Csk 通过局部调控Src 家族激酶和桩蛋白信号来控制白细胞渗出。
Front Immunol. 2024 Oct 28;15:1480152. doi: 10.3389/fimmu.2024.1480152. eCollection 2024.
4
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.非受体酪氨酸激酶:它们在肿瘤进展和耐药中的结构及机制作用
Cancers (Basel). 2024 Aug 2;16(15):2754. doi: 10.3390/cancers16152754.
5
Lck Function and Modulation: Immune Cytotoxic Response and Tumor Treatment More Than a Simple Event.Lck的功能与调节:免疫细胞毒性反应及肿瘤治疗——远非简单事件
Cancers (Basel). 2024 Jul 24;16(15):2630. doi: 10.3390/cancers16152630.
6
Identification of oxidative phosphorylation-related genes in moyamoya disease by combining bulk RNA-sequencing analysis and machine learning.通过整合批量RNA测序分析和机器学习鉴定烟雾病中氧化磷酸化相关基因
Front Genet. 2024 Jun 10;15:1417329. doi: 10.3389/fgene.2024.1417329. eCollection 2024.
7
Investigating the Protective Effects of a Citrus Flavonoid on the Retardation Morphogenesis of the Oligodendroglia-like Cell Line by Rnd2 Knockdown.研究一种柑橘类黄酮对Rnd2基因敲低所致少突胶质细胞样细胞系形态发育迟缓的保护作用。
Neurol Int. 2023 Dec 26;16(1):33-61. doi: 10.3390/neurolint16010003.
Apoptosis regulation by the tyrosine-protein kinase CSK.
酪氨酸蛋白激酶CSK对细胞凋亡的调控
Front Cell Dev Biol. 2022 Dec 12;10:1078180. doi: 10.3389/fcell.2022.1078180. eCollection 2022.
4
Regulation, targets and functions of CHK.CHK的调控、靶点及功能
Front Cell Dev Biol. 2022 Dec 9;10:1068952. doi: 10.3389/fcell.2022.1068952. eCollection 2022.
5
Csk αC Helix: A Computational Analysis of an Essential Region for Conformational Transitions.Cskα螺旋:构象转变关键区域的计算分析
J Phys Chem B. 2022 Dec 22;126(50):10587-10596. doi: 10.1021/acs.jpcb.2c05408. Epub 2022 Dec 13.
6
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.抑制 ACK1 介导的 C 端Src 激酶磷酸化可抵抗前列腺癌免疫检查点阻断耐药。
Nat Commun. 2022 Nov 14;13(1):6929. doi: 10.1038/s41467-022-34724-5.
7
A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.一个基于磷酸化酪氨酸的信号转导模块,利用SPOP、CSK和LYN来控制Toll样受体(TLR)诱导的干扰素调节因子(IRF)活性。
Sci Adv. 2022 Jul 8;8(27):eabq0084. doi: 10.1126/sciadv.abq0084.
8
SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.SH3 结构域突变选择性地破坏 Csk 同源二聚体或 PTPN22 结合。
Sci Rep. 2022 Apr 7;12(1):5875. doi: 10.1038/s41598-022-09589-9.
9
Acute Csk inhibition hinders B cell activation by constraining the PI3 kinase pathway.急性 Csk 抑制通过限制 PI3 激酶途径来阻碍 B 细胞的激活。
Proc Natl Acad Sci U S A. 2021 Oct 26;118(43). doi: 10.1073/pnas.2108957118.
10
ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK Signaling by Regulating CSK.ELTD1通过调节CSK,经由MAPK/ERK信号通路促进胃癌细胞增殖、侵袭及上皮-间质转化。
Int J Gen Med. 2021 Aug 27;14:4897-4911. doi: 10.2147/IJGM.S325495. eCollection 2021.